Shares of Ranbaxy were up after New York's attorney general said it plans to announce a settlement with US units of Ranbaxy and Teva. Shares of Sun Pharma Advanced Research Company gained on the news that Sun Pharma had received USFSA approval to sell a drug to treat Osteoporosis, a bone-weakening disease.
Ranbaxy and Teva will pay New York $300,000 for unlawfully restricting competition.
Among sectoral indices, the BSE Capital Goods (0.53%), BSE IT (0.64%) and BSE Consumer Durables (1.31%) were trading in the green.
Among key Asian indices, the Shanghai Composite (0.94%), Jakarta Composite (0.41%) and Straits Times (0.52%) were the major gainers.